Skip to main content

即将在2020 ADA发布新的NAFLD/NASH临床前模型数据

Written by Customer Service on . Posted in Public Companies.

圣地亚哥，加利福尼亚, June 10, 2020 (GLOBE NEWSWIRE) — 中美冠科生物技术有限公司今日宣布了新的专利NAFLD/NASH临床前模型研发数据。这些数据将在第80届美国糖尿病协会及冠科自己的网络研讨会进行展示。
这些新的数据共享了NAFLD/NASH模型通过改变冠科现有的高度转化临床前啮齿类动物及NHP模型的饮食喂养结构的发展。这些模型将助力于目前缺乏已通过审批的，针对NAFLD/NASH药物的临床前研发项目。与此同时，在2020年ADA的海报中，冠科还会支持6月12号的国际NASH日，并且在当天有针对NAFLD/NASH模型发展的演讲。冠科将主持一系列免费的线上活动，并提供这些资源共享，您可以通过这个链接进行注册：CrownBio.com/ADA20.中美冠科高级副总裁汪亦欣博士如是说：“我们将继续加强我们高度转化的临床前模型的平台，并承诺在将来不断的加快NAFLD/NASH的研究，我们非常荣幸能在6月的网络活动中共享我们在这个领域取得的最新的研究成果”中美冠科的ADA线上活动将从6月12日持续到16日，您可以通过这个链接进入：CrownBio.com/ADA20，您可以在线与冠科心血管及代谢疾病的专业团队进行沟通。同时还会有包括NAFLD/NASH，糖尿病，肥胖，肾脏和心血管疾病相关的资源可以在线浏览和下载。关于中美冠科：中美冠科生物技术有限公司（CrownBio）隶属于JSR生命科学公司，是一家全球性的药物发现和开发公司，为推进肿瘤、炎症、心血管及代谢疾病的研究提供转化医学平台。中美冠科拥有数量庞大的相关模型库和预测工具组合，能够为客户提供优秀的临床候选药物筛选服务。有关详细信息，请访问：https://www.crownbio.comhttps://www.jsrlifesciences.com媒体联络:中美冠科生物技术有限公司 
Jody Barbeau
pr@crownbio.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.